Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis

Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0

Abstract

Background Self-Monitoring of Blood Glucose (SMBG) is considered as a key factor in management of people with diabetes which is a growing and cost demanding health problem. The purpose of this study was to investigate the effect of comprehensive patient management using structured SMBG on metabolic control as well as its cost consequence analysis. Methods Sixty subjects were recruited in an observational study for a period of 6 months. They were provided with the ACCU-CHEK 360degrees View tool to fill in the values of the 7-point blood glucose profiles in three consecutive days during the study on a monthly basis. Changes in metabolic control were assessed by HbA1c and lipid profile measurement at the beginning and at the end of the study. In addition, cost consequence analysis was done considering different level of health care professionals with or without insurance coverage. The Average Cost Effectiveness Ratio (ACER) as well as Cost saving analysis were calculated and compared. Results The analysis showed significant reduction in HbA1c during the 6-month period in all subjects (P = 0.000). Furthermore, a positive effect was observed on lipid profile. The cost of endocrinologist's visit in private sector was estimated to be 265.76 USD while this figure was149.15 USD for general practitioner in public sector with insurance coverage. Total complications and mortality cost saving was 154.8 USD. The lowest ACER was calculated for intervention with general practitioner in public sector with insurance coverage.Conclusion Structured SMBG results in significant improvement of glycemic status. Moreover, it is more cost saving in public sector with insurance coverage. It seems that general practitioner visits with insurance coverage is the most affordable option for people with type 2 diabetes.

Authors and Affiliations

Mojtaba Malek, Rokhsareh Aghili, Mohammad E Khamseh, Shahin Yarahmadi, Amir Farshchi

Keywords

Related Articles

The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial

The clustering of metabolic abnormalities defined as metabolic syndrome is now both a public health and a clinical problem .While interest in herbal medicine has greatly increased, lack of human evidence to support effic...

Effects of IMOD and Angipars on mouse D-galactose-induced model of aging

The aim of this study was to evaluate the effects of two registered herbal drugs called IMOD and Angipars on mouse model of. Aging was induced by D-galactose (500 mg/kg) administered to animals for 6 weeks through drinki...

The major role of toxicology societies in global collaborations - a call to action

The science of toxicology in all of its various aspects is, of necessity, a global one. The production and release of potentially toxic chemicals is increasing in many parts of the world. While this can cause local envir...

Development of a validated HPLC method for the simultaneous determination of flavonoids in Cuscuta chinensis Lam. by ultra-violet detection

Cuscuta species known as dodder, have been used in traditional medicine of eastern and southern Asian countries as liver and kidney tonic. Flavonoids are considered as the main biologically active constituents in Cuscuta...

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children

Background and purpose of the study Intractable seizures are a subgroup of epileptic disorders challenging the physicians' skills to become controlled. Showing resistance towards common pharmacotherapy, they demand newer...

Download PDF file
  • EP ID EP135285
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

Mojtaba Malek, Rokhsareh Aghili, Mohammad E Khamseh, Shahin Yarahmadi, Amir Farshchi (2012). Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis. DARU Journal of Pharmaceutical Sciences, 20(0), 1-13. https://europub.co.uk/articles/-A-135285